ArticleAnnals of translational medicine2022

Comparing albuvirtide plus ritonavir-boosted lopinavir regimen to two nucleotide reverse transcriptase inhibitors plus ritonavir-boosted lopinavir in HIV-infected individuals who failed initial treatment: a retrospective comparative cohort study.

Liyu Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.